DARPA

Advanced Weapons Developer D.A.R.P.A. Invested $25M in Moderna’s mRNA Vax in 2013

The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million "to research and develop its messenger RNA therapeutics" nearly 8 years ago.

DARPA Unveils ‘COVID Microchip,’ Claims Not For Surveillance Purposes

The Pentagon unveiled a coronavirus microchip that it claims can detect illness and prevent the spread of COVID-19.

Latest news

- Advertisement -spot_img